Page 2 - Motor Disorders Third Edition
P. 2

© 2015 by David S. Younger, MD, PC
All rights reserved. This book is protected by copyright. No part of this book may be reproduced in any form or by any means,
including photocopying, or utilized by any information storage and retrieval system without written permission from the
copyrightowner, except for brief quotations embodied in critical articles and reviews.Materials appearing in this book prepared
by individuals as part of their official duties as US government employees are not covered by the above-mentioned copyright.

ISBN 978-1-931332-93-4 (epub)
ISBN 978-1-931332-92-7 (PDF ebook)

Design and composition by Dorie McClelland, springbookdesign.com.

Cover engraving from Dictionnaire, Universal, D’Histoire Naturelle, Atlas, by Charles D’Orbigny,
Chez Les Editeurs, L. Houssiaux Et C, Paris, 1861

Index by S.A. Fifer, [email protected].

Care has been taken to con?rm the accuracy of the information presented and to describe generally accepted practices. However,
the authors, editors, and publisher are not responsible for errors or omissions or for any consequences from application of the
information in this book and make no warranty, expressed or implied, with respect to the currency, completeness, or accuracy of
the contents of the publication. Application of this information in a particular situation remains the professional responsibility of
the practitioner. ?e authors, editors, and publisher have exerted every e?ort to ensure that drug selection and dosage set forth in
this text are in accordance with current recommendations and practice at the time of publication. However, in view of ongoing
research, changes in government regulations, and the constant ?ow of information relating to drug therapy and drug reactions, the
reader is urged to check the package insert for each drug for any change in indications and dosage and for added warnings and
precautions. ?is is particularly important when the recommended agent is a new or infrequently employed drug. Some drugs and
medical devices presented in this publication have Food and Drug Administration (FDA) clearance for limited use in restricted
research settings. It is the responsibility of health care providers to ascertain the FDA status of each drug or device planned for use
in their clinical practice.

                                                      a division of Rothstein Associates Inc
                                                Philip Jan Rothstein, FBCI, Publisher

                                                             4 Arapaho Road
                                            Brookfield, Connecticut 06804-3104 USA

                                                  203.740.7400 • 203.740.7401 fax
                                                           [email protected]

                                                    www.rothsteinpublishing.com
                                                           www.rothstein.com
   1   2   3   4   5   6   7